Close X
Wednesday, December 25, 2024
ADVT 
International

Trudeau commits $25M in aid for Palestinians

Darpan News Desk The Canadian Press, 28 May, 2021 03:27 PM
  • Trudeau commits $25M in aid for Palestinians

Canada will provide $25 million to Palestinian civilians affected by the recent conflict between the Israelis and the Palestinians in Gaza Strip and the West Bank, Prime Minister Justin Trudeau said Friday.

Trudeau said in a news release the funding will go directly to experienced organizations which will help the most vulnerable Palestinian civilians cope with the impacts of the recent conflict.

"The recent violence in the region is alarming — we have all seen the disturbing images of displaced civilians, loss of life, and pain inflicted on families," Trudeau said.

Canada's aid will include $10 million for urgent food assistance, shelter, water, sanitation and hygiene and psychosocial support for children and $10 million to support humanitarian and rebuilding efforts, such as vital medical infrastructure.

Trudeau said Canada will also dedicate up to $5 million for peace-building initiatives that advance the goal of a comprehensive, just and lasting peace between the Palestinians and the Israelis.

International Development Minister Karina Gould said the aid will provide timely humanitarian assistance and support people in Gaza to recover from the damage caused by the recent conflict.

Last week, Canada welcomed a ceasefire ending the 11-day war between Israel and Hamas that left hundreds of people dead.

At least 230 Palestinians were killed, including 65 children and 39 women, with 1,710 people wounded, according to the Gaza Health Ministry. Twelve people in Israel were killed.

Before the recent conflict, the United Nations estimated that approximately 1.57 million people in Gaza, out of a total population of 2 million, were in need of humanitarian assistance.

In December, Canada committed funding of $90 million over three years to respond to the rising needs of vulnerable Palestinian refugees.

This report was first published by The Canadian Press on May 28, 2021.

—-

MORE International ARTICLES

WATCH: France Alert as Terrorist Strikes Nice Again | "Islamic Terrorism" says President Macron

WATCH: France Alert as Terrorist Strikes Nice Again |
WATCH: A deadly terrorist attack has targeted France. According to Police, three people have been killed in a knife attack at a church in the French city of Nice.

WATCH: France Alert as Terrorist Strikes Nice Again | "Islamic Terrorism" says President Macron

Trump formally lets Canadian aluminum off hook

Trump formally lets Canadian aluminum off hook
The U.S. president formally signed a proclamation today exempting Canadian aluminum exports from punitive Section 232 tariffs.

Trump formally lets Canadian aluminum off hook

Prince Harry says ignorance no excuse for unconscious bias

Prince Harry says ignorance no excuse for unconscious bias
Harry talked about racial inequality and social justice in a video discussion with the Black Lives Matter activist Patrick Hutchinson as part of the GQ Heroes Conference, which is being broadcast this week.

Prince Harry says ignorance no excuse for unconscious bias

Halloween goes on at the White House with a few twists

Halloween goes on at the White House with a few twists
In years past, the president and first lady personally handed out candy to the costume-clad kids. This year, the treats were provided separately as participants walked along a path on the South Lawn.

Halloween goes on at the White House with a few twists

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir